- Noticias y Estudios analíticos
- CBONDS OLD
Amgen Inc. is an American multinational biopharmaceutical company headquartered in California. Amgen Inc. is an independent biotechnology medicines company that discovers, develops, manufactures and markets medicines for grievous illnesses. The Company focuses solely on human therapeutics and concentrates on innovating novel medicines based on advances in cellular and molecular biology.
|25/10/2021||Fitch Ratings affirms Amgen at "BBB+" (LT Int. Scale (foreign curr.) credit rating); outlook stable|
|09/08/2021||New bond issue: Amgen issued international bonds (US031162DC10) with a 3% coupon maturing in 2052|
|09/08/2021||New bond issue: Amgen issued international bonds (US031162DA53) with a 2.8% coupon maturing in 2041|
|09/08/2021||New bond issue: Amgen issued international bonds (US031162CZ14) with a 2% coupon maturing in 2032|